PharmaSGP SE to Redeem Shares Amid Upcoming Delisting

PharmaSGP SE announced plans to redeem its treasury shares, which account for approximately 4.06% of its share capital. The redemption aims to utilize new authorization for acquiring treasury shares, set for resolution at the upcoming Annual General Meeting. This move aligns with the firm's strategy ahead of its delisting.

The redemption will not affect shareholders' economic interests, as treasury shares do not carry rights. It will, however, increase the arithmetic ownership percentage of shareholders. Main stakeholders, FUTRUE GmbH and MVH Beteiligungs- und Beratungs-GmbH, will hold approximately 94% of the share capital, enabling a potential squeeze-out under German law.

The decision reflects PharmaSGP's intention to streamline its shareholding structure in anticipation of market changes.